Research News and Research

RSS

Oral bisphosphonates outweigh the risk associated with jaw disease

A commonly prescribed osteoporosis drug is associated with a slightly elevated risk of developing the rare, but serious condition, osteonecrosis of the jaw; nonetheless the risk remains extremely low. These findings are published online in the Journal of Dental Research, the official journal of the International and American Associations for Dental Research.

14 Feb 2011

New research shows link between two pesticides and Parkinson's disease

New research shows a link between use of two pesticides, rotenone and paraquat, and Parkinson's disease. People who used either pesticide developed Parkinson's disease approximately 2.5 times more often than non-users.

14 Feb 2011

Obesity associated with decreased risk of open-angle glaucoma in women, not men

Obesity may be associated with higher eye pressure and a decreased risk of open-angle glaucoma in women but not men, according to a report posted online today that will appear in the May issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

14 Feb 2011

Researchers find placentas of preeclampsic women have abundance of genes linked with immune system regulation

Researchers at North Carolina State University have discovered that the placentas of women who suffer preeclampsia during pregnancy have an overabundance of a gene associated with the regulation of the body's immune system. Their discovery may lead to improved screening and prenatal care for these patients and their babies.

14 Feb 2011

Study: Women with anorexia draw themselves with prominently different characteristics

Women suffering from anorexia or bulimia draw themselves with prominently different characteristics than women who do not have eating disorders and who are considered of normal weight. This has been revealed in a new joint study from the University of Haifa, Soroka University Medical Center and Achva Academic College, Israel, published in The Arts in Psychotherapy.

14 Feb 2011

Heavy alcohol intake can lead to increased risk of AF

Atrial Fibrillation is the most common cardiac arrhythmia. Its name comes from the fibrillating of the heart muscles of the atria, instead of a coordinated contraction. The result is an irregular heartbeat, which may occur in episodes lasting from minutes to weeks, or it could occur all the time for years. Atrial fibrillation alone is not in itself generally life-threatening, but it may result in palpitations, fainting, chest pain, or congestive heart failure.

14 Feb 2011

NIH awards renewal grant to BMC's CARE unit to expand education of physicians-in-training

The Clinical Addiction Research and Education Unit in the Section of General Internal Medicine at BMC was recently awarded a $1,886,087 renewal grant from the National Institutes of Health to expand its education of physicians-in-training to become sophisticated implementers of substance use screening, assessment and treatment research.

14 Feb 2011

Rapid approvals for medical devices by FDA leads to increased recalls: Study

According to a latest study many medical devices recalled in recent years by the Food and Drug Administration (FDA) because they posed a high risk to patients were not rigorously studied before being approved for patient use. The study, appearing on the web site of The Archives of Internal Medicine, said that most medical devices that were the subject of high-risk recalls from 2005 to 2009 had been cleared through a regulatory pathway with little testing. This included external heart defibrillators, hospital infusion pumps and mechanical ventilators.

14 Feb 2011

U-Systems completes pivotal study for automated breast ultrasound cancer screening

U-Systems, the leader in automated breast ultrasound today announced the completion of a pivotal ROC Reader Study for automated breast ultrasound cancer screening. Conducted by University of Chicago, an acclaimed pioneer in women's heath research, the multi-reader, multi-case (MRMC) ROC Reader Study was carried-out to evaluate the sensitivity of somo•v™ Automated Breast Ultrasound (ABUS) together with a screening mammogram in detecting breast cancer in women with dense breast tissue.

14 Feb 2011

Elsevier / MEDai launch new version of Pinpoint Review clinical surveillance system for hospitals

Elsevier / MEDai, a leading provider of advanced clinical analytic healthcare solutions, announced today the launch of the latest version of Pinpoint Review(R), its real-time, clinical surveillance system for hospitals. The new version will feature an expanded set of clinical watch triggers, expanded core measure alerts and three new predictions: ICU Admission Prediction, Length of Stay Prediction and Mortality Prediction.

14 Feb 2011

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

Tianyin Pharmaceutical Co., Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine, branded generics and other pharmaceuticals, announced the financial results for the second quarter of Fiscal Year 2011.

14 Feb 2011

AP: Crooks find Medicare Part D an easy target

Crooks are taking advantage of lax oversight in Medicare's Part D prescription drug program to obtain highly addictive drugs including oxycodone, Ritalin, and methadone, according to results of a federal probe.

14 Feb 2011

BioTime to merge Glycosan with OrthoCyte

BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's wholly-owned subsidiary, OrthoCyte Corporation. The acquisition is expected to close by March 18, 2011.

14 Feb 2011

Questcor's pricing issue

After Questcor Pharmaceuticals raised the price of the drug Acthar, its sole product, more than 10-fold in 2007, its shares began a climb from pennies to $14 and change. Acthar

14 Feb 2011

IMRIS fourth quarter sales increase 26% to $25.2 million

IMRIS Inc. today reported its results for the fourth quarter 2010 highlighted by record financial performance that included strong revenue growth and the Company's second consecutive quarter of positive EBITDA1 and earnings. All figures are reported in Canadian dollars.

14 Feb 2011

Best Practices publishes new report on 'Innovations in Patient-Focused Initiatives'

For the biopharmaceutical industry, the changing healthcare marketplace has increased the importance - and difficulty - of interacting with patients to improve outcomes. New technologies and access restrictions have created both opportunities and challenges for approaching and engaging patient populations to improve disease control.

14 Feb 2011

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it has entered into a Cooperative Research and Development Agreement with the National Cancer Institute's (NCI) Cancer Therapy Evaluation Program (CTEP) to collaborate on the conduct of a randomized Phase 2 trial of ZYBRESTAT in combination with bevacizumab in patients with relapsed ovarian cancer.

14 Feb 2011

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

A new strategic plan from an arm of the National Institutes of Health envisions scientists being able to identify genetic bases of most single-gene disorders and gaining new insights into multi-gene disorders in the next decade. This should lead to more accurate diagnoses, new drug targets and the development of practical treatments for many who today lack therapeutic options, according to the plan from the National Human Genome Research Institute (NHGRI).

14 Feb 2011

First Edition: February 14, 2011

Today's headlines are focused on President Obama's budget proposal and what it does and does not include.

14 Feb 2011

Public-sector research has had an immediate effect on improving public health: Study

AUTM President Ashley Stevens, D. Phil. (Oxon), CLP is the lead author of The Role of Public Sector Research in the Discovery of Drugs and Vaccines, a paper published in the Feb. 10 issue of The New England Journal of Medicine.

14 Feb 2011

Research News and Research

Oral bisphosphonates outweigh the risk associated with jaw disease

New research shows link between two pesticides and Parkinson's disease

Obesity associated with decreased risk of open-angle glaucoma in women, not men

Researchers find placentas of preeclampsic women have abundance of genes linked with immune system regulation

Study: Women with anorexia draw themselves with prominently different characteristics

Heavy alcohol intake can lead to increased risk of AF

NIH awards renewal grant to BMC's CARE unit to expand education of physicians-in-training

Rapid approvals for medical devices by FDA leads to increased recalls: Study

U-Systems completes pivotal study for automated breast ultrasound cancer screening

Elsevier / MEDai launch new version of Pinpoint Review clinical surveillance system for hospitals

Tianyin Pharmaceutical's second quarter revenue increases 69.6% to $25.3 million

AP: Crooks find Medicare Part D an easy target

BioTime to merge Glycosan with OrthoCyte

Questcor's pricing issue

IMRIS fourth quarter sales increase 26% to $25.2 million

Best Practices publishes new report on 'Innovations in Patient-Focused Initiatives'

OXiGENE, NCI/CTEP and GOG collaborate on ZYBRESTAT Phase 2 study in relapsed ovarian cancer

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

First Edition: February 14, 2011

Public-sector research has had an immediate effect on improving public health: Study

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News